白细胞介素2促进小鼠硬化性胆管炎肝脏调节性T细胞反应并减轻胆汁性纤维化
在Mdr2-/-小鼠硬化性胆管炎模型中,肝内CD8+淋巴细胞扩增而调节性T细胞(Treg)减少与胆汁损伤和纤维化相关;IL-2/抗IL-2免疫复合物扩增Treg可下调Opn和Tnf、减少CD8+细胞并减轻胆汁损伤和纤维化;胆道闭锁婴儿肝内CD8+细胞浸润与Opn表达相关,且Opn转录与Treg相关基因mRNA负相关。
要点
- Mdr2-/-小鼠出生后14-30天肝内CD8+淋巴细胞扩增、Treg收缩,伴随血清ALP和ALT升高。
- 抗CD25清除Treg加重肝内CD8+细胞、Opn表达和纤维化;IL-2c扩增Treg则减轻损伤和纤维化。
- 表达CD39的Treg在体外更有效抑制Mdr2-/-小鼠肝内CD8+淋巴细胞增殖。
核心结论
- 肝内CD8+淋巴细胞驱动小鼠硬化性胆管炎的胆道损伤和纤维化,其增殖受肝内Treg通过嘌呤能通路控制,该通路对IL-2c有反应,提示Treg导向的低剂量IL-2治疗可能被考虑用于硬化性胆管炎。
研究设计与样本
- 研究采用Mdr2-/-小鼠硬化性胆管炎模型,并在胆道闭锁婴儿中观察肝内CD8+细胞浸润与Opn及Treg相关基因表达的关系。
主要发现
- 在幼年Mdr2-/-小鼠出生后14-30天,肝内CD8+淋巴细胞扩增,肝内Treg收缩与血清ALT和ALP水平升高同时发生。
- 在该时间段用抗体清除肝内CD8+淋巴细胞可降低ALP水平和促纤维化细胞因子Opn的表达。
- 出生后7-30天用抗CD25抗体清除肝内Treg,增加肝内CD8+ T细胞、Opn表达和纤维化。
- 用IL-2c扩增肝内Treg可下调肝脏Opn和Tnf表达、降低肝内CD8+淋巴细胞频率并减轻胆道损伤和纤维化。
- IL-2c治疗上调肝脏Treg表达CD39,体外表达CD39的Treg比不表达CD39的Treg更有效抑制Mdr2-/-小鼠肝内CD8+淋巴细胞增殖。
临床怎么用
- 原文结论提示Treg导向的低剂量IL-2治疗可能被考虑用于硬化性胆管炎。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In the multidrug resistance protein 2 (Mdr2)-/- mouse model, low phospholipid bile instigates biliary epithelial injury, sterile inflammation, and fibrosis, thereby recapitulating disease mechanisms implicated in biliary atresia (BA) and primary sclerosing cholangitis. We hypothesize that T lymphocytes contribute to the biliary injury and fibrosis in murine sclerosing cholangitis (SC) and that they are susceptible to suppression by regulatory T cells (Tregs). In juvenile Mdr2-/- mice, intrahepatic CD8+ lymphocytes were expanded, and contraction of intrahepatic Tregs coincided with rising serum alanine transferase and alkaline phosphatase (ALP) levels between days 14-30 of life. Antibody-mediated depletion of intrahepatic CD8+ lymphocytes during that time reduced ALP levels and the expression of osteopontin (Opn), a pro-fibrogenic cytokine. Depletion of intrahepatic Tregs with anti-CD25 antibody between days 7-30 increased intrahepatic CD8+ T cells, Opn expression, and fibrosis. Conversely, expansion of intrahepatic Tregs with interleukin 2/anti-interleukin 2 immune complexes (IL-2c) downregulated hepatic expression of Opn and Tnf, reduced frequency of intrahepatic CD8+ lymphocytes, and diminished biliary injury and fibrosis. Treatment with IL-2c upregulated hepatic Treg expression of CD39, an ectonucleotidase capable of hydrolyzing pro-inflammatory adenosine triphosphate. In vitro, Tregs expressing CD39 suppressed the proliferation of hepatic CD8+ lymphocytes from Mdr2-/- mice more efficiently than those lacking CD39. In infants with BA, infiltration of interlobular bile ducts with CD8+ cells was associated with biliary expression of Opn and its transcription was negatively correlated with mRNA expression of Treg-associated genes. Conclusion: Hepatic CD8+ T lymphocytes drive biliary injury and fibrosis in murine SC. Their proliferation is controlled by hepatic Tregs through the purinergic pathway, which is responsive to IL-2c, suggesting that Treg-directed low-dose Il-2 treatment may be considered as therapy for SC.
引用
- Taylor AE, Carey AN, Kudira R, et al. Interleukin 2 Promotes Hepatic Regulatory T Cell Responses and Protects From Biliary Fibrosis in Murine Sclerosing Cholangitis. Hepatology. 2018. PMID: 29698570. doi:10.1002/hep.30061
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。